Thursday - December 18, 2025

Category Archives: Pharmaceuticals & Biotech

Hypercholesterolemia Clinical Trial Pipeline Accelerates as 25+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s, “Hypercholesterolemia Pipeline Insight, 2025” report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in Hypercholesterolemia pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product … Continue reading →

Chronic Periodontitis Clinical Trial Pipeline Gains Momentum: 10+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s, “Chronic Periodontitis Pipeline Insight, 2025” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Chronic Periodontitis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment … Continue reading →

MicroCaps: BMXI, RNWF, ECGS, ECOX In The News

Several emerging micro-cap companies released notable updates this week, highlighting corporate restructuring, mergers, uplisting preparations, and strategic infrastructure partnerships. Below is a concise, investor-focused breakdown of the key developments now drawing market attention. Brookmount Gold (OTC: BMXI) North American Asset … Continue reading →

Intravenous Immunoglobulin Market to Experience Notable Growth in Forecast Span by 2034, DelveInsight Predicts | Takeda, Mitsubishi Tanabe Pharma, AbbVie, Prothya Biosolutions

The Key Intravenous Immunoglobulin Companies in the market include – Takeda, Mitsubishi Tanabe Pharma, AbbVie, Prothya Biosolutions, and others. DelveInsight’s “Intravenous Immunoglobulin Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Intravenous Immunoglobulin, historical and forecasted … Continue reading →

Peraso Technologies (NASDAQ: PRSO) Expands Across FWA, Defense, and Edge AI as Benchmark Reaffirms Buy

Peraso Technologies, Inc. (NASDAQ: PRSO) is showing accelerating business momentum as adoption strengthens across its core and adjacent markets, including Fixed Wireless Access (FWA), military and defense communications, and emerging Edge AI applications, according to a recent analyst update. The … Continue reading →

Hypoparathyroidism Market Insights Highlight Expanding Outlook Till 2034, DelveInsight Evaluates | Bridgebio/Calcil ytix Therapeutics, Ascendis Pharma, EnteraBio, Shire

The Key Hypoparathyroidism Companies in the market include – Ascendis Pharma, EnteraBio, Bridgebio/Calcil ytix Therapeutics, Shire, and others. DelveInsight’s “Hypoparathyroidism Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Hypoparathyroidism, historical and forecasted epidemiology as well … Continue reading →

Multiple Myeloma Clinical Trial Pipeline Gains Momentum: 75+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s “Multiple Myeloma Pipeline Insights 2025” report provides comprehensive insights about 75+ Multiple Myeloma Companies and 80+ pipeline drugs in the Multiple Myeloma pipeline landscape. It covers the Multiple Myeloma pipeline drug profiles, including clinical and nonclinical stage products. It … Continue reading →

Myelodysplastic Syndrome Clinical Trial Pipeline Accelerates as 120+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s, “Myelodysplastic Syndrome Pipeline Insights 2025” report provides comprehensive insights about 120+ companies and 150+ pipeline drugs in Myelodysplastic Syndrome pipeline landscape. It covers the Myelodysplastic Syndrome pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →